| Literature DB >> 31920225 |
Chakrabarti Rajkalyan1, Anurag Tewari2, Shilpa Rao3, Rafi Avitsian4.
Abstract
The refractory seizures have significant impact on the quality of life and increase long term neurologic and non-neurologic complications. Implantation of Stereotactic Electroencephalography (SEEG) leads is one of the newer surgical techniques intended to localize seizure foci with higher accuracy than the conventional methods. Most of the commonly utilized anesthetic agents depress EEG waveforms affecting intra operative monitoring during these surgeries. Hence, the anesthetic goals include a stable induction and maintenance with agents which have minimal effect on EEG. This article discusses the peri-operative considerations of multiple anti-epileptic medications, recent advances in anesthetic management, and important post-operative concerns. Copyright:Entities:
Keywords: Anesthesia; SEEG; epilepsy surgery; intra operative monitoring; intra-operative EEG; refractory seizures; seizure foci; stereotactic electroencephalography
Year: 2019 PMID: 31920225 PMCID: PMC6939570 DOI: 10.4103/joacp.JOACP_342_18
Source DB: PubMed Journal: J Anaesthesiol Clin Pharmacol ISSN: 0970-9185
Anesthetic goals for Stereo-Electroencephalography (SEEG)
| 1 | Smooth Induction and emergence |
| 2 | Maintain adequate cerebral perfusion pressure |
| 3 | To ensure absolute patient immobility |
| 4 | To cause least interference with intra-operative EEG monitoring |
| 5 | To enhance the chance of seizure detection |
| 6 | Treatment of any complications |
Anesthetic drugs and their effect on the Electroencephalogram
| Drug | Effect on EEG Frequency | Effect in EEG Amplitude | Burst Suppression |
|---|---|---|---|
| Isoflurane | Yes, >1.5 MAC | ||
| Subanesthetic | Loss of α, ↑ frontal β | ↓ | |
| Anesthetic | Frontal 4- to 8-Hz activity | ↑ | |
| Increasing dose >1.5 MAC | Diffuse θ and δ → burst suppression→silence | ↑→0 | |
| Enflurane | Yes, >1.5 MAC | ||
| Subanesthetic | Loss of α, ↑ frontal β | ↓ | |
| Anesthetic | Frontal 7- to 12-Hz activity | ↑ | |
| Increasing dose >1.5 MAC | Spikes/spike and slow waves→Burst suppression; hypocapnia→Seizures | ↑↑ | |
| Halothane | Not seen in clinically useful dose range | ||
| Low dose | ↑ Frontal 10- to 20-Hz activity | ↓ | |
| Moderate dose | Frontal 10- to 15-Hz activity | ↑ | |
| Increasing dose >1.5 MAC | Diffuse θ, slowing with increasing dose | ↑ | |
| Sevoflurane | Similar to equi-MAC | Similar to equi-MAC | Similar to equi-MAC |
| Desflurane | Similar to equi-MAC dose of isoflurane | Similar to equi-MAC dose of isoflurane | Yes, >1.2 MAC |
| Nitrous oxide (alone) | Frontal fast oscillatory activity (>30 Hz) | ↑, especially with inspired concentration >50% | No |
| Barbiturates | Yes, with high doses | ||
| Low dose | Fast frontal β activity | Slight ↑ | |
| Moderate dose | Frontal α frequency spindles | ↑ | |
| Increasing high dose | Diffuse δ → burst suppression→silence | ↑↑↑→ 0 | |
| Etomidate | Yes, with high doses | ||
| Low dose | Fast frontal β activity | ↓ | |
| Moderate dose | Frontal α frequency | ↑ | |
| Increasing high dose | Diffuse δ → burst suppression→silence | ↑↑→ 0 | |
| Propofol | Yes, with high doses | ||
| Low dose | Loss of α, ↑ frontal β | ↓ | |
| Moderate dose | Frontal α, waxing-waning a | ↑ | |
| Increasing high dose | Diffuse δ → burst suppression→silence | ↑↑→0 | |
| Ketamine | No | ||
| Low dose | Loss of α, ↑ variability | ↑↓ | |
| Moderate dose | Frontal rhythmic θ | ↑ | |
| High dose | Polymorphic δ, some β | ↑↑ (β is low amplitude) | |
| Benzodiazepines | No | ||
| Low dose | Loss of α, increased frontal β activity | ↓ | |
| High dose | Frontally dominant δ and θ | ↑ | |
| Opiates | No | ||
| Low dose | Loss of β, α slows | ↔↑ | |
| Moderate dose | Diffuse θ, some δ | ↑ | |
| High dose | δ, often synchronized | ↑↑ |
α = alpha (8-13 Hz) frequency; β = beta (>13 Hz) frequency; δ = delta (Note: Arrows indicate direction of change; number of arrows indicates the magnitude of change. Adapted from Black S, Mahla ME, Cucchiara RF. Neurologic Monitoring. In RD Miller. (ed). Anesthesia. New York: Churchill Livingston, 1994:1323